Streetbeat News

Price Targets

GNFT

HC Wainwright & Co. analyst Ed Arce has reiterated a Buy rating on Genfit (NASDAQ:GNFT) and maintained a price target of $13.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 10:38 am

STRO

HC Wainwright & Co. has reiterated its Buy rating for Sutro Biopharma (NASDAQ:STRO) and maintained a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 10:33 am

CAPR

HC Wainwright & Co. has maintained a Buy rating on Capricor Therapeutics and raised the price target from $40 to $77, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 10:29 am

VALN

HC Wainwright & Co. has maintained a Buy rating on Valneva (NASDAQ:VALN) but lowered the price target from $23 to $20.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 10:22 am

MDWD

HC Wainwright & Co. has reiterated its Buy rating on MediWound (NASDAQ:MDWD) and maintained a price target of $28.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 10:11 am

MELI

Redburn Atlantic has initiated coverage on MercadoLibre with a Buy rating and set a price target of $2800.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 10:05 am

AX

Needham analyst Kyle Peterson has initiated coverage on Axos Financial with a Buy rating and set a price target of $82.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 9:53 am

ORKA

Stifel analyst Alex Thompson has initiated coverage on Oruka Therapeutics with a Buy rating and set a price target of $49.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 9:11 am

AMZN

Pivotal Research has initiated coverage on Amazon.com with a Buy rating and set a price target of $260.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 9:09 am

ANIP

Piper Sandler has initiated coverage on ANI Pharmaceuticals with an Overweight rating and set a price target of $68.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 9:08 am